Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Expert insights for taking a cell or gene therapy company from vision to reality
|
Apr 15, 2024 |
Regulators' strategies for managing the surge in cell and gene therapies
|
Feb 15, 2024 |
How Creative Destruction Lab accelerates the advanced therapies industry
|
Jan 15, 2024 |
The synergy solution: How public-private partnerships advance regenerative medicine
|
Dec 15, 2023 |
Catalysts of change: Canada’s research hubs are shaping the future of biomanufacturing
|
Nov 15, 2023 |
From code to cure: Exploring the synergies of artificial intelligence and regenerative medicine
|
Oct 15, 2023 |
Stuck in the sixties: The fight to fast-forward access to better cancer treatment
|
Apr 14, 2023 |
CAR T therapies: Engineering immune cells to treat cancer
|
Mar 14, 2023 |
Protecting the product of innovation: IP and commercialization in cell and gene therapies
|
Feb 14, 2023 |
Mentoring: making moves to maximize career growth
|
Jan 15, 2023 |
Unlocking the potential of induced pluripotent stem cells
|
Dec 14, 2022 |
Training tomorrow’s talent: building the biomanufacturing workforce
|
Nov 14, 2022 |
You get what you pay for
|
Jun 14, 2022 |
A busy intersection: Ethics and policy in cell and gene therapies
|
May 14, 2022 |
The Future’s Synthetic
|
Mar 14, 2022 |
Moving from A to B
|
Feb 14, 2022 |
Chaperoning innovation through the valley of death
|
Jan 14, 2022 |
The importance of educating the public about cell and gene therapies
|
Dec 14, 2021 |